LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum.
Ariane Wohlfarth, Wolfgang Weinmann, Sebastian Dresen
Analytical and bioanalytical chemistry April 1, 2010 DOI: 10.1007/s00216-009-3394-4 via PubMed
Summary
AI-generated from the abstractA liquid chromatography-tandem mass spectrometry (LC-MS/MS) method can simultaneously identify 35 substances, including 31 new designer drugs plus cathinone, methcathinone, phencyclidine, and ketamine. The method covers amphetamine derivatives (e.g., 2C-B, DOB, PMA), tryptamine derivatives (e.g., DMT, 5MeO-DMT), and piperazine derivatives (e.g., BZP, mCPP). After solid-phase extraction and gradient elution, detection limits range from 1.0 to 5.0 ng/mL, matrix effects from 65% to 118%, and extraction efficiencies from 72% to 90%. The assay is selective for all tested substances.
Study at a glance
| Characteristics | Method development and validation Peer reviewed |
|---|---|
| Keywords | Designer drugs detection Nps identification Drug screening Analytical toxicology Substance detection |
| Citations | 128 |
| Key finding | The LC-MS/MS method can selectively identify 35 psychoactive substances with detection limits between 1.0 and 5.0 ng/mL. |
Abstract
Since the late 1990s and early 2000s, derivatives of well-known designer drugs as well as new psychoactive compounds have been sold on the illicit drug market and have led to intoxications and fatalities. The LC-MS/MS screening method presented covers 31 new designer drugs as well as cathinone, methcathinone, phencyclidine, and ketamine which were included to complete the screening spectrum. All but the last two are modified molecular structures of amphetamine, tryptamine, or piperazine. Among the amphetamine derivatives are cathinone, methcathinone, 3,4-DMA, 2,5-DMA, DOB, DOET, DOM, ethylamphetamine, MDDMA, 4-MTA, PMA, PMMA, 3,4,5-TMA, TMA-6 and members of the 2C group: 2C-B, 2C-D, 2C-H, 2C-I, 2C-P, 2C-T-2, 2C-T-4, and 2C-T-7. AMT, DPT, DiPT, MiPT, DMT, and 5MeO-DMT are contained in the tryptamine group, BZP, MDBP, TFMPP, mCPP, and MeOPP in the piperazine group. Using an Applied Biosystems LC-MS/MS API 365 TurboIonSpray it is possible to identify all 35 substances. After addition of internal standards and mixed-mode solid-phase extraction the analytes are separated using a Synergi Polar RP column and gradient elution with 1 mM ammonium formate and methanol/0.1% formic acid as mobile phases A and B. Data acquisition is performed in MRM mode with positive electro spray ionization. The assay is selective for all tested substances. Limits of detection were determined by analyzing S/N-ratios and are between 1.0 and 5.0 ng/mL. Matrix effects lie between 65% and 118%, extraction efficiencies range from 72% to 90%.